WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)
Pill imprint WATSON 3359 WATSON 3359 has been identified as Tacrolimus 5 mg.
Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 3359 WATSON 3359
- Strength:
- 5 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcineurin inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-3359
- Inactive Ingredients:
- lactose anhydrous
croscarmellose sodium
hypromelloses
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Red No. 40
More about tacrolimus
Consumer resources
- Tacrolimus
- Tacrolimus capsules
- Tacrolimus extended-release capsules
- Tacrolimus oral and injection
- Tacrolimus Intravenous (Advanced Reading)
- Tacrolimus Oral, Intravenous (Advanced Reading)
- Other brands: Prograf, Hecoria, Astagraf XL, Envarsus XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
